Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


MacroGenics reported $302.4M in Market Capitalization this June of 2023, considering the latest stock price and the number of outstanding shares.

Market Capitalization Change
AbbVie ABBV:US USD 281.15B 4.65B
Amgen AMGN:US USD 129.1B 11.04B
AstraZeneca AZN:LN USD 174.08B 252.77M
Biogen BIIB:US USD 40.17B 294M
Bristol-Myers Squibb BMY:US USD 145.78B 7.2B
Daiichi Sankyo 4568:JP JPY 9.39T 1.23T
Eli Lilly LLY:US USD 327.06B 20.56B
Genmab GEN:DC DKK 170.84B 23.16B
Geron GERN:US USD 1.1B 181M
Gilead Sciences GILD:US USD 103.55B 4.13B
Immunogen IMGN:US USD 868M 227M
J&J JNJ:US USD 402.75B 59.1B
Karyopharm Therapeutics KPTI:US USD 443M 58M
MacroGenics MGNX:US USD 443M 30M
Merck & Co MRK:US USD 269.98B 11.32B
Mirati Therapeutics MRTX:US USD 2.16B 449M
Pfizer PFE:US USD 230.29B 57.33B
Puma Biotechnology PBYI:US USD 144M 50M
Regeneron Pharmaceuticals REGN:US USD 89.83B 11.26B
Roche Holding ROG:VX CHF 242.33B 20.77B
Seattle Genetics SGEN:US USD 37.89B 14.02B
Xencor XNCR:US USD 1.67B 114M